Xiliang Wang
- Molecular Biology top 10%
- Materials Chemistry top 10%
- Biomedical Engineering top 5%
- Infectious Diseases top 10%
- Animal Science and Zoology top 5%
- Co-authors
- Dingren BiBabacar NgomYancheng GuoYijuan LongHuzhi ZhengLiping LiangPing TengXiaoxiao Huang
- Topics
- Microbial infections and disease research (12 papers)Probiotics and Fermented Foods (6 papers)Pharmacogenetics and Drug Metabolism (5 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiliang Wang
80 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 143
- Molecular Biology 968
- Materials Chemistry 596
- Biomedical Engineering 566
- Infectious Diseases 198
- Animal Science and Zoology 187
Countries citing papers authored by Xiliang Wang
This map shows the geographic impact of Xiliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiliang Wang more than expected).
Fields of papers citing papers by Xiliang Wang
This network shows the impact of papers produced by Xiliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiliang Wang. The network helps show where Xiliang Wang may publish in the future.
Co-authorship network of co-authors of Xiliang Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Xiliang Wang. A scholar is included among the top collaborators of Xiliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiliang Wang. Xiliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 66 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 6 | |
| 9 | 17 | |
| 10 | 2 | |
| 11 | 29 | |
| 12 | 33 | |
| 13 | 33 | |
| 14 | 23 | |
| 15 | 3 | |
| 16 | 50 | |
| 17 | 10 | |
| 18 | Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody | 1 |
| 19 | [Expression of ryanodine receptor isoforms in airway smooth muscle cells of rats]. | 1 |
| 20 | 34 |
About Xiliang Wang
Xiliang Wang is a scholar working on Microbiology, Animal Science and Zoology and Pharmacology, having authored 81 papers that have together received 2.6k indexed citations. Recurring topics across this work include Microbial infections and disease research (12 papers), Probiotics and Fermented Foods (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Microbiology (160 citations), Animal Science and Zoology (187 citations) and Molecular Biology (968 citations). Xiliang Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Dingren Bi, Babacar Ngom, Yancheng Guo, Yijuan Long, Huzhi Zheng, Liping Liang, Ping Teng, Xiaoxiao Huang, Rui Zhu and Qinlong Wang. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.